Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Urine excretion is the systemic physiological process by which the kidneys eliminate metabolic waste products and maintain internal fluid and electrolyte homeostasis (National Center for Biotechnology Information [NCBI], 2023). It is not a discrete molecular target like a receptor or enzyme; instead, it represents the functional output of complex renal mechanisms including glomerular filtration, tubular reabsorption, and tubular secretion (StatPearls, 2023). In a pharmacological context, urine excretion is frequently used as a clinical endpoint or a pharmacodynamic biomarker to assess the efficacy of drugs like diuretics or SGLT2 inhibitors (PubMed, 2022). These drugs do not bind to 'excretion' itself but rather target specific proteins such as ion transporters or water channels within the nephron to modulate the volume and composition of urine (American Journal of Kidney Diseases, 2021). Because it is a macroscopic physiological process involving numerous molecular pathways, labeling it as a single therapeutic target is technically incorrect for drug discovery purposes. Monitoring urine excretion is vital for managing patients with cardiovascular and renal diseases to prevent complications such as fluid overload or severe dehydration (NIH, 2023).
Urine excretion is a physiological outcome rather than a molecular target. Therapeutic agents modulate this process by interacting with specific renal molecular targets such as the Na-K-2Cl symporter (NKCC2), the sodium-chloride symporter (NCC), aquaporin channels, or vasopressin receptors to alter the filtration, reabsorption, and secretion of water and solutes (StatPearls, 2023).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Urine excretion.